Ketoprofen-poly(vinylpyrrolidone) physical interaction

Abstract Amorphous solid solutions were obtained in different proportions by dissolving ketoprofen (Ket) and poly(vinylpyrrolidone) (PVP) K30 in methanol and by evaporating them under reduced pressure. Their physical properties were studied by powder X-ray diffraction and by differential scanning calorimetry and compared to that of same physical mixtures (PM). The interaction of Keto and poly(vinylpyrrolidone) K30 in the solid state was then investigated by 13 C NMR CPMAS analysis. The results indicated that in the Ket–(PVP) co-precipitates, the ket molecules, interacting with their carboxylic group through hydrogen bonding with the poly(vinylpyrrolidone) moieties, are molecularly and irregularly dispersed within the amorphous solvendum that acts as mechanical substratum for amorphous stabilization. In their simple PM, no evidence exists of the Ket-polymer interaction during the considered time interval.

[1]  Bruno C. Hancock,et al.  What is the True Solubility Advantage for Amorphous Pharmaceuticals? , 2000, Pharmaceutical Research.

[2]  W. Higuchi,et al.  Inhibition of sulfathiazole crystal growth by polyvinylpyrrolidone. , 1970, Journal of pharmaceutical sciences.

[3]  R. Skwierczynski.  Disorder, molecular mobility, and solid-state kinetics: the two-environment model. , 1999, Journal of pharmaceutical sciences.

[4]  S. Clas,et al.  Crystallization inhibition in solid dispersions of MK-0591 and poly(vinylpyrrolidone) polymers. , 2000, Journal of pharmaceutical sciences.

[5]  D. Craig,et al.  The mechanisms of drug release from solid dispersions in water-soluble polymers. , 2002, International journal of pharmaceutics.

[6]  S. Hoag,et al.  Influence of various drugs on the glass transition temperature of poly(vinylpyrrolidone): a thermodynamic and spectroscopic investigation. , 2001, International journal of pharmaceutics.

[7]  T. Arita,et al.  Inhibitory Effect of Polyvinylpyrrolidone on the Crystallization of Drugs , 1978 .

[8]  H. Sunada,et al.  Solid-State Interaction of Ibuprofen with Polyvinylpyrrolidone , 1995 .

[9]  S. Srčič,et al.  Thermal analysis of glassy pharmaceuticals , 1995 .

[10]  Bruno C. Hancock,et al.  Inhibition of indomethacin crystallization in poly(vinylpyrrolidone) coprecipitates. , 1995, Journal of pharmaceutical sciences.

[11]  Robert Simha,et al.  On a General Relation Involving the Glass Temperature and Coefficients of Expansion of Polymers , 1962 .

[12]  Bruno C. Hancock,et al.  Characteristics and significance of the amorphous state in pharmaceutical systems. , 1997, Journal of pharmaceutical sciences.

[13]  J Dressman,et al.  Improving drug solubility for oral delivery using solid dispersions. , 2000, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[14]  G. Zografi,et al.  The Relationship Between the Glass Transition Temperature and Water Vapor Absorption by Poly(vinylpyrrolidone) , 1990, Pharmaceutical Research.

[15]  S. Furlanetto,et al.  Utilization of differential scanning calorimetry as a screening technique to determine the compatibility of ketoprofen with excipients , 1995 .

[16]  M. Summers,et al.  The effect of wetting agents on the dissolution of indomethacin solid dispersion systems , 1986 .